Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans
NCT00591890
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Interventions
DRUG:
indibulin
Sponsor
Alaunos Therapeutics